Interv Akut Kardiol. 2023;22(3):129-135 | DOI: 10.36290/kar.2023.024

Isolated tricuspid regurgitation: a case report and overview of the issue

Zuzana Hlubocká, Michaela Zemková, David Zemánek
2. interní klinika kardiologie a angiologie VFN a 1. LF UK, Praha

Isolated tricuspid regurgitation is the second most common cause of secondary tricuspid insufficiency. It results from tricuspid annulus dilatation leading to malcoaptation in patients without significant left-sided heart disease or pulmonary hypertension. Isolated tricuspid regurgitation typically occurs in elderly patients with a high prevalence of atrial fibrillation and severe right atrial dilatation; therefore, it is also referred to as atrial tricuspid regurgitation. We present a case of an 85-year-old woman with symptomatic severe isolated tricuspid regurgitation. Imaging methods (transthoracic and transoesophageal echocardiography, cardiac magnetic resonance imaging) were used to quantify the haemodynamic severity of valvular regurgitation and assess right ventricular function as well as tricuspid annulus morphology. Cardiac catheterization revealed normal coronary angiography and mild postcapillary pulmonary hypertension. The patient was discussed by the heart team and transcatheter intervention of the tricuspid valve was recommended. Transcatheter edge-to-edge repair was successfully performed resulting in clinical improvement of the patient's symptoms. Severe isolated tricuspid regurgitation is associated with excess mortality. Tricuspid valve surgery improves survival; however, it carries a significant operative risk. Transcatheter interventions are a promising option for symptomatic patients with isolated tricuspid regurgitation who are not suitable for surgery.

Keywords: tricuspid regurgitation, isolated, valve disease, echocardiography, transcatheter intervention.

Received: March 30, 2023; Revised: August 6, 2023; Accepted: August 7, 2023; Published: November 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hlubocká Z, Zemková M, Zemánek D. Isolated tricuspid regurgitation: a case report and overview of the issue. Interv Akut Kardiol. 2023;22(3):129-135. doi: 10.36290/kar.2023.024.
Download citation

References

  1. Topilsky Y, Maltais S, Inojosa JM, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. J Am Coll Cardiol Img. 2019;12:433-42. Go to original source... Go to PubMed...
  2. Vieitez JM, Monteqgudo JM, Mahia P, et al. New insights of tricuspid regurgitation: a large­‑scale prospective cohort study. Eur Heart J Cardiovasc Imaging. 2021;22(2):196-202. Go to original source... Go to PubMed...
  3. Praz F, Muraru D, Kreidel F, et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021;17:791-808. Go to original source... Go to PubMed...
  4. Prihadi EA, Delgado V, Leon MB, et al. Morphologic types of tricuspid regurgitation. J Am Coll Cardiol Img. 2019;12:491-9. Go to original source... Go to PubMed...
  5. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2021;00:1-72. Go to original source... Go to PubMed...
  6. Hahn RT. State­‑of­‑the­‑Art Review of Echocardiographic Imaging in the Evaluation and Treatment of Functional Tricuspid Regurgitation. Circ Cardiovasc Imaging. 2016;9:e005332. Go to original source... Go to PubMed...
  7. Lancellotti P, Pibarot P, Chambers J, et al. Multi­‑modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022;23:e171-e232. Go to original source... Go to PubMed...
  8. Hahn RT, Zamorano J. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18:1342-43. Go to original source... Go to PubMed...
  9. Topilsky Y, Tribouilloy Ch, Michelena HI, et al. Pathophysiology of tricuspid regurgitation. Quantitative Doppler echocardiographic assessment of respiratory dependence. Circulation. 2010;122:1505-1513. Go to original source... Go to PubMed...
  10. Kim HK, Kim YJ, Park JS, et al. Determinants of the severity of functional tricuspid regurgitation. Am J Cardiol. 2006;98:236-42. Go to original source... Go to PubMed...
  11. Park JB, Lee SP, Lee JH, Yoon YE, et al. Quantification of right ventricular volume and function using single­‑beat three­‑dimensional echocardiography: a validation study with cardiac magnetic resonance. J Am Soc Echocardiogr. 2016;29:392-401. Go to original source... Go to PubMed...
  12. Muraru D, Badano LP, Nagata Q, et al. Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography. Eur Heart J Cardiovsc Imaging. 2020;21:10-21. Go to original source... Go to PubMed...
  13. Hundley WG, Blumke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010; 55:2614-2662. Go to original source... Go to PubMed...
  14. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown­‑up congenital heart disease. Eur Heart J. 2010;31:2915-2957.
  15. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitatoin on long­‑term survival J Am Coll Cardiol. 2004;43:405-9. Go to original source... Go to PubMed...
  16. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. J Am Coll Cardiol Img. 2014;7:1185-1194. Go to original source... Go to PubMed...
  17. Wang TKM, Mentias A, Akyuz K, et al. Effect of Tricuspid Valve Repair on Survival in Patients With Isolated Sever Tricuspid Regurgitation. Am J Cardiol. 2022;162:163-169. Go to original source... Go to PubMed...
  18. Parolari A, Barili F, Pilozzi A, et al. Ring or suture annuloplasty for tricuspid regurgitation? A meta­‑analysis review. Ann Thorac Surg. 2014;98:2255-2263. Go to original source... Go to PubMed...
  19. Bouleti C, Juliard J­‑M, Himbert D, et al. Tricuspid valve and percutaneous approach: No longer the forgotten valve. Archives Cardiovasc Disease. 2016;109:55-66. Go to original source... Go to PubMed...
  20. Sanon S, Cabalka AK, Babaliaros A, et al. Transcatheter Tricuspid Valve­‑in­‑Valve and Valve­‑in­‑Ring impalntation for degenerated surgical prosthesis. JACC: Cardiovasular Intervention. 2019;12(15):403-412. Go to original source... Go to PubMed...
  21. Rodés­‑Cabau J, Hahn RT, Latib A, et al. Transcatheter Therapies for Treating Tricuspid Regurgitation. J Am Coll Cardiol. 2016;67(15):1829-1845. Go to original source... Go to PubMed...
  22. LaPar DJ, Likosky DS, Zhang M, et al. Development of risk prediction model and clinical risk score for isolated tricuspid valve surgery. Ann Thorac Surg. 2018;106:129-36. Go to original source... Go to PubMed...
  23. Dreyfus J, Ghalem N, Garbarz E, et al. Timing of referral of patients with severe isolated tricuspid valve regurgitation to surgeons (from a French Nationwide Database). Am J Cardiol. 2018;122:323-6. Go to original source... Go to PubMed...
  24. Dreyfus J, Audureau E, Bohbot Y, et al. TRI­‑SCORE: a new risk score for in­‑hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J. 2022;43(7)654-662. Go to original source... Go to PubMed...
  25. Kim YJ, Kwon DA, Kim HK, et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation. 2009;120(17):1672-1678. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.